Ion channels as a therapeutic target for renal fibrosis

离子通道作为肾纤维化的治疗靶点

阅读:1

Abstract

Renal ion channel transport and electrolyte disturbances play an important role in the process of functional impairment and fibrosis in the kidney. It is well known that there are limited effective drugs for the treatment of renal fibrosis, and since a large number of ion channels are involved in the renal fibrosis process, understanding the mechanisms of ion channel transport and the complex network of signaling cascades between them is essential to identify potential therapeutic approaches to slow down renal fibrosis. This review summarizes the current work of ion channels in renal fibrosis. We pay close attention to the effect of cystic fibrosis transmembrane conductance regulator (CFTR), transmembrane Member 16A (TMEM16A) and other Cl(-) channel mediated signaling pathways and ion concentrations on fibrosis, as well as the various complex mechanisms for the action of Ca(2+) handling channels including Ca(2+)-release-activated Ca(2+) channel (CRAC), purinergic receptor, and transient receptor potential (TRP) channels. Furthermore, we also focus on the contribution of Na(+) transport such as epithelial sodium channel (ENaC), Na(+), K(+)-ATPase, Na(+)-H(+) exchangers, and K(+) channels like Ca(2+)-activated K(+) channels, voltage-dependent K(+) channel, ATP-sensitive K(+) channels on renal fibrosis. Proposed potential therapeutic approaches through further dissection of these mechanisms may provide new therapeutic opportunities to reduce the burden of chronic kidney disease.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。